Debut Biotechnology Closes $2.6M Seed Round to Bring Continuous Biomanufacturing of High-Value Molecules to Pharma

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2ZZJODz
via IFTTT